Radiosynovectomy of the hip joint - preliminary experience

Marek Marcin Chojnowski; Danuta Owczarczak; Maria Teresa Płazińska; Marek Dedecjus; Leszek Królicki

doi:10.5114/reum/166608

Radiosynovectomy of the hip joint - preliminary experience

Reumatologia. 2023;61(3):186-190. doi: 10.5114/reum/166608. Epub 2023 Jul 2.

Authors

Marek Marcin Chojnowski¹, Danuta Owczarczak¹, Maria Teresa Płazińska², Marek Dedecjus¹, Leszek Królicki²

Affiliations

¹ Department of Oncological Endocrinology and Nuclear Medicine, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
² Department of Nuclear Medicine, Medical University of Warsaw, Poland.

Abstract

Introduction: Radiosynovectomy (RSV) is a minimally invasive method of treating and controlling joint inflammation refractory to conventional pharmacotherapy. It consist in intraarticular injection of radioactive colloids which irradiate the inflamed synovial membrane to cause its subsequent involution. Despite the fact that hip joint involvement is quite common in systemic inflammatory arthropathies, hip joint RSVs are rarely performed. The aim of this paper is to assess to safety and efficacy of hip joint radioisotope treatment.

Material and methods: We retrospectively analyzed the effects of 21 hip joint RSVs performed in 14 patients (10 female, 4 male; aged 8 to 79; mean age 48 years). Before the RSV, all the patients underwent clinical and ultrasound examination. The radiosynovectomies were performed using rhenium-186 sulfide under ultrasound guidance. Each patient underwent post-therapeutic scintigraphy to assess intraarticular distribution of the radiopharmaceutical. The effects of the treatment were assessed clinically and ultrasonographically during at least 2 follow-up visits 3 and 6 months after the RSV.

Results: In 9 cases, we observed complete resolution of symptoms 3 and 6 months after the RSV. Four patients had only a partial response and required repeated treatment, and all responded well to the second RSV. In 4 patients the treatment had no significant effect, and no repeated treatment attempt was made. All the responders suffered from inflammatory arthropathies; the non-responders had osteoarthritis, with no history of systemic diseases. In all the patients, no significant adverse effects were observed; in particular there were no radiation burns or infections. All post-therapeutic scintigrams showed proper, intraarticular distribution of the radiopharmaceutical.

Conclusions: Radiosynovectomy of the hip joint in systemic joint diseases, especially performed using ultrasound-guidance, is a safe and effective treatment modality.

Keywords: arthritis; hip joint; nuclear medicine; radiosynovectomy.